Evidence map›Paper›PMID 32727499›Full record

ArticleRetrovirology2020

Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions.

Belete Ayele Desimmie, Rik Schrijvers, Jonas Demeulemeester, Doortje Borrenberghs, Caroline Weydert, Wannes Thys, Sofie Vets, Barbara Van Remoortel, Johan Hofkens, Jan De Rijck and 5 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Retrovirology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Belete Ayele DesimmieDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Rik SchrijversDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Jonas DemeulemeesterDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Doortje BorrenberghsLaboratory for Photochemistry and Spectroscopy, KU Leuven, Celestijnenlaan 200F, 3001, Heverlee, Flanders, Belgium.
Caroline WeydertDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Wannes ThysDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Sofie VetsDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Barbara Van RemoortelDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Johan HofkensLaboratory for Photochemistry and Spectroscopy, KU Leuven, Celestijnenlaan 200F, 3001, Heverlee, Flanders, Belgium.
Jan De RijckDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Jelle HendrixLaboratory for Photochemistry and Spectroscopy, KU Leuven, Celestijnenlaan 200F, 3001, Heverlee, Flanders, Belgium.
Norbert BannertCentre for HIV and Retrovirology, Robert Koch Institute, Nordufer 20, 13353, Berlin, Germany.
Rik GijsbersDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Frauke ChristDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium.
Zeger DebyserDepartment of Pharmaceutical and Pharmacological Sciences, Laboratory for Molecular Virology and Gene Therapy, KU Leuven, Kapucijnenvoer 33, 3000, Louvain, Flanders, Belgium. Zeger.debyser@med.kuleuven.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Identifiers

PMID32727499
PMCPMC7389342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.